Anti-tumour immunotherapy using dendritic-cell-derived exososmes

Project Information

SUSANNE GABRIELSSON

Grant agreement ID: QLK3-CT-1999-51289

Start date 1 January 2000

End date 31 December 2001

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 125 900,00

EU contribution € 125 900,00

Coordinated by

INSTITUT CURIE
France

Objective

Development of a new technique for quantifying anti-tumour immune responses based on dendritic cell -derived exosomes and evaluation of exosomes as vaccine vectors.

Fields of science

• natural sciences › biological sciences › cell biology
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines
• medical and health sciences › basic medicine › immunology › immunotherapy

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-3. - Key action The "Cell factory"

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

INSTITUT CURIE

• EU contribution: No data
• Address: Rue d'Ulm 26 ; 75248 PARIS ; France
• Total cost: No data